KCM
ALIM

Kennedy Capital Management’s Alimera Sciences ALIM Stock Holding History

Kennedy Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-22,217
Closed -$467K – 759
2017
Q1 		$467K Buy
+22,217
New +$428K 0.01% 696

Other funds holding ALIM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Kennedy Capital Management's ALIM Position: Q2 2017 in Review

Kennedy Capital Management sold out of Alimera Sciences (ALIM) in Q2 2017, closing a stake of 22,217 shares — an estimated $467K sold.

Kennedy Capital Management first reported a position in ALIM in Q1 2017 and held it in 1 quarter. The position peaked at $467K in Q1 2017. 38 funds tracked by Wall St. Rank hold ALIM as of Q2 2017.

  • Kennedy Capital Management reported no remaining Alimera Sciences position as of Q2 2017 after selling out during the quarter.
  • Kennedy Capital Management sold 22,217 Alimera Sciences shares in Q2 2017, an estimated $467K.
  • Kennedy Capital Management first reported a position in Alimera Sciences in Q1 2017 and held it in 1 quarter.
  • Kennedy Capital Management's Alimera Sciences position peaked at $467K in Q1 2017.
  • 38 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2017.

Based on Kennedy Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.